Muneesh Tewari

Development of human protein reference database as an initial platform for approaching systems biology in humans.

RNAi on the apoptosis TRAIL: the mammalian cell genetic screen comes of age.

A map of the interactome network of the metazoan C. elegans.

Systematic interactome mapping and genetic perturbation analysis of a C. elegans TGF-beta signaling network.

Functional genomic analysis of RNA interference in C. elegans.

The limits of reductionism in medicine: could systems biology offer an alternative?

The clinical applications of a systems approach.

The 14-3-3 protein FTT-2 regulates DAF-16 in Caenorhabditis elegans.

Network modeling links breast cancer susceptibility and centrosome dysfunction.

Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.

MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.

Circulating microRNAs as stable blood-based markers for cancer detection.

Empirically controlled mapping of the Caenorhabditis elegans protein-protein interactome network.

Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells.

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells.

Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

Limitations and possibilities of small RNA digital gene expression profiling.

Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.

The next thing in prognostic molecular markers: microRNA signatures of cancer.

Activation of the MEK-S6 pathway in high-grade ovarian cancers.

Nanostructure-enhanced laser tweezers for efficient trapping and alignment of particles.

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.

Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.

HIF induces human embryonic stem cell markers in cancer cells.

Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity.

An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.

Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.